Medindia
Medindia LOGIN REGISTER
Advertisement

Ventria Hires Director of Global Regulatory Affairs

Wednesday, November 28, 2007 General News
Advertisement
JUNCTION CITY, Kan., Nov. 27 Ventria Bioscience announcedtoday that Quentin B. Kubicek, Ph.D. would be joining the company as Director,Global Regulatory Affairs.
Advertisement

Dr. Kubicek joins Ventria with more than 20 years experience in regulatoryaffairs and policy development related to plant biotechnology. Prior tojoining Ventria, Quentin worked with InterAmerican Institute for Cooperationon Agriculture (IICA) where he developed regulatory policies on behalf ofseveral Latin American and Caribbean governments for products derived frombiotechnology. Quentin has also held regulatory positions with DupontNutrition and Health and the United States Department of Agriculture. Hereceived his Ph.D. in Molecular Biology from Texas A&M University.
Advertisement

"Quentin's proven leadership, scientific credentials and his experienceworking in regulatory affairs and policy development will help accelerateVentria's growth as we achieve our vision for affordable healthcaresolutions," said Scott Deeter, President and CEO, Ventria Bioscience. "Quentinwill lead Ventria's Global Regulatory Affairs Group," he said.

"I am excited to be joining the Ventria team at a time of rapid growth sothat I can utilize my experience to help Ventria achieve its vision ofdelivering affordable health care products to the global community," saidKubicek.

A recent child health study showed that Ventria's Lactiva and Lysominhelped reduce the duration of diarrhea in children by 30 percent when added torehydration solutions. Childhood diarrhea is the second leading killer ofchildren, claiming 2 million lives annually according to the World HealthOrganization.

For more information, see our website at Ventria Biosciencehttp://www.ventria.com

Statements in this announcement other than historical data and informationconstitute forward looking statements that involve risks and uncertaintiesthat could cause actual results to differ materially from those stated orimplied by such forward-looking statements. Potential risks and uncertaintiesmay include, but are not limited to, recent changes in senior management,fluctuations in operating results, market conditions and changes in technologyand increased competition.

SOURCE Ventria Bioscience
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close